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The mission of the National Center on Birth Defects and Developmental Disabilities (NCBDDD) 
is to improve the health of children and adults by preventing birth defects and developmental 
disabilities, and complications of heredity blood disorders; promoting optimal child 
development, and the health and wellness among children and adults living with disabilities.  In 
carrying out this mission, this organization:  (1) conducts public health research, epidemiological 
investigations, and program demonstrations directed toward preventing birth defects and 
developmental disabilities, and complications of hereditary blood disorders, optimal fetal, infant, 
and child development, and promoting the health and wellness of people with disabilities, 
including the prevention of secondary conditions; (2) plans, develops, establishes, and maintains 
systems of surveillance and monitoring the population for these conditions; (3) operates regional 
centers for the conduct of applied epidemiological research on these conditions; (4) provides 
information and education to health care providers, public health professionals, and the public on 
these conditions; (5) provides technical assistance, consultation, capacity building through 
technology transfer, grants, cooperative agreements, contracts, and other means to State, local, 
international, and nonprofit organizations to prevent and control these conditions; (6) provides 
training in the epidemiology of these conditions for health professionals within and outside the 
United States; (7) translates scientific findings into intervention, prevention, and health 
promotion strategies; (8) conducts evaluations of programs to determine effectiveness; (9) 
coordinates activities with other CDC organizations and Federal and non-Federal health 
agencies, as appropriate.  (Approved 10/20/2003) 
 
Office of the Director (CUB1) 
 
(1) Directs, manages, and coordinates the activities of the National Center on Birth Defects and 
Developmental Disabilities (NCBDDD); (2) develops goals and objectives; provides leadership, 
policy formulation, scientific oversight, and guidance in program planning and development; (3) 
coordinates NCBDDD program activities with other CDC components, Federal agencies, 
international organizations, State and local health agencies, business and industry, voluntary 
organizations, and community-based organizations; (4) coordinates technical assistance to states, 
other nations and international organizations; (5) coordinates with medical, scientific, and other 
professional organizations interested in birth defects prevention, pediatric genetics, 
developmental disabilities prevention, and disabilities and health, and prevention of 
complications of hereditary blood disorders; (6) advises the Director, CDC, on policy matters 
concerning NCBDDD activities; and (7) serves as primary liaison between NCBDDD and the 
CDC Office of the Associated Director for Communications and its associated research and 
practice. (Approved 4/20/2011) 
 
Resource Management Office (CUB12) 
 
(1) Plans, coordinates, and provides administrative and management advice and guidance for 
NCBDDD; (2) provides and coordinates Center-wide administrative, management, and support 
services in the areas of fiscal management, personnel, travel, procurement, facility management, 
and other administrative services; (3) prepares annual budget plans and budget justifications; 
(4) coordinates NCBDDD requirements relating to contracts, grants, cooperative agreements, and 
reimbursable agreements; (5) develops and implements administrative policies, procedures, and 
operations, as appropriate, for NCBDDD, and prepares special reports and studies, as required, in 
the administrative management areas; (6) maintains liaison with related staff offices and other 
officials of CDC.  (Approved 3/15/2002) 
 
Division of Congenital and Developmental Disorders (CUBB) 
 
(1) Conducts research to determine the causes and prevention of birth defects and developmental 
disabilities; (2) maintains and expands support for state-based surveillance; (3) evaluates the 
effectiveness of efforts to prevent birth defects and developmental disabilities; (4) conducts and 
disseminates findings of epidemiologic research, investigations, demonstrations, and programs 
directed toward the prevention of selected adverse reproductive outcomes that are 
environmentally related; (5) provides assistance to State and local health departments on 
community exposures to terotogenic, mutagenic, embryotoxic, other environmental agents, and 
genetic influences adversely interfering with normal growth and development; (6) conducts 
research and develops programs to identify women at high risk of an alcohol-exposed pregnancy 
and to fund epidemiologic and clinical research studies aimed at early identification and 
intervention of children affected by prenatal alcohol exposure; (7) works closely with 
international organizations and entities in developing strategies and programs for reducing the 
number of birth defects and developmental disabilities; (8) develops and evaluates prevention 
strategies and provides training, technical consultation, and assistance to States and localities in 
developing their capacity for planning, establishing, and maintaining surveillance and prevention 
programs; (9) maintains and oversees funding and technical assistance to state-based institutions 
(e.g., the Centers for Birth Defects Research and Prevention that seek causes and promotes 
prevention of birth defects); (10) plans, develops, establishes, and maintains systems of 
surveillance including registries for monitoring, evaluating and disseminating information; (11) 
assists in increasing the capacity of States to prevent and control birth defects and developmental 
disabilities through training, technology transfer, grants, cooperative agreements, contracts, and 
other means; (12) provides information and education to the public; (13) provides services, 
consultation, technical assistance, and information to States, localities, other Federal agencies, 
international organizations, and other public and private organizations; (14) provides training in 
the epidemiology to professionals throughout the U.S. and abroad; and (15) collaborates and 
coordinates activities with other CIOs and HHS agencies.  (Approved 1/28/2016) 
 
Office of the Director (CUBB1) 
(1) Manages, directs, and coordinates the research agenda and activities of the division;  
(2) provides leadership and guidance on strategic planning, policy, program and project priority 
planning and setting, program management, and operations; (3) establishes division goals, 
objectives, and priorities; (4) monitors progress in implementation of projects and achievement 
of objectives; (5) plans, allocates, and monitors resources; (6) provides management, 
administrative, and support services, and coordinates with appropriate NCBDDD offices on 
program and administrative matters; (7) provides liaison with other CDC organizations, other 
governmental agencies, international organizations, and other outside groups; (8) provides 
support for internal scientific advisory groups; (9) provides scientific leadership and guidance to 
the division to assure highest scientific quality and professional standards; and (10) provides 
coordinative support for CDC’s efforts to reduce adverse consequences from birth defects, 
developmental disabilities, and pediatric genetic conditions. (Approved 3/22/2006) 
 
Birth Defects Branch (CUBBB) 
 
(1) Designs and conducts epidemiologic and genetic research to identify causes and risk factors 
of birth defects; (2) conducts and evaluates interventions to improve infant and child health by 
preventing or reducing the adverse consequences of birth defects; (3) designs and conducts 
surveillance of selected birth defects to identify rates, trends, and patterns of occurrence, and to 
evaluate the effectiveness of prevention programs; (4) disseminates findings of studies to the 
scientific and public health communities, and to the general public; (5) provides technical 
assistance to state and local agencies on surveillance of birth defects, epidemiologic research, 
prevention program design and evaluation, and prevention effectiveness research; (6) funds and 
coordinates grant and cooperative agreement programs and other extramural activities to improve 
the knowledge base for the prevention of birth defects through surveillance, epidemiologic 
research, and applies research of preventive interventions; (7) coordinates activities with other 
CDC functional units, HHS, other federal agencies, and appropriate private organizations 
regarding research and prevention programs for birth defects; (8) works with international 
organizations in developing strategies for the prevention of birth defects; and  
(9) disseminates findings of research through direct contact with health authorities, publication 
and distribution of special reports, publication in scientific and technical journals, conference 
presentations, and other appropriate means. (Approved 3/22/2006) 
 
Prevention Research and Translation Branch (CUBBC) 
 
(1) Modifies the impact of prenatal exposures leading to adverse physical and developmental 
impairments in infants, children, and adults including integrating successful prevention programs 
into social and medical environments, and evaluating innovative, effective, and strategic health 
promotion programs; (2) develops, implements, evaluates, and disseminates education and 
communication interventions that lead to the prevention of birth defects and developmental 
disabilities; (3) designs and conducts surveillance of preventable birth defects and developmental 
disabilities to identify rates, trends, and patterns of occurrence, and to evaluate the effectiveness 
of prevention programs; (4) disseminates findings of epidemiologic studies to the scientific and 
public health communities, and to the general public; (5) conducts prevention effectiveness 
research to evaluate interventions strategies for the prevention of birth defects and developmental 
disabilities; (6) identifies and monitors major preconception, prenatal and perinatal risks, and 
protective factors for fetal alcohol spectrum disorders (FASD) and other prenatal alcohol-
attributable conditions; (7) provides technical assistance to state and local agencies on 
surveillance, epidemiologic research, prevention program design and evaluation, and prevention 
effectiveness research; (8) funds and coordinates grant and cooperative agreement programs and 
other extramural activities to improve the knowledge base for the prevention of birth defects and 
developmental disabilities through surveillance, epidemiologic research, and applies research of 
preventive interventions; (9) coordinates activities with other CDC functional units, HHS, other 
federal agencies and appropriate private organizations regarding research and prevention 
programs for birth defects and developmental disabilities; (10) works with international 
organizations in developing strategies for the prevention of birth defects and developmental 
disabilities; and (11) disseminates finding of research through direct contact with health 
authorities, publication and distribution of special reports, publication in scientific and technical 
journals, conference presentations, and other appropriate means.  (Approved 1/28/2016) 
 
Developmental Disabilities Branch (CUBBD) 
 
(1) Designs and conducts surveillance of developmental disabilities to identify rates, trends, and 
patterns of occurrence, and to evaluate the effectiveness of prevention programs; (2) conducts 
epidemiologic studies of developmental disabilities to identify causes and risk factors for these 
conditions; (3) disseminates findings of epidemiologic studies to the scientific and public health 
communities and to the general public; (4) conducts prevention effectiveness research to evaluate 
interventions strategies for the prevention of developmental disabilities; (5) conducts 
epidemiologic studies to identify and describe specific conditions and long-term outcomes of 
developmental disabilities; (6) provides technical assistance to state and local agencies on 
surveillance of developmental disabilities, epidemiologic research, prevention program design 
and evaluation, and prevention effectiveness research; (7) funds and coordinates grant and 
cooperative agreement programs and other extramural activities to improve the knowledge base 
for the prevention of developmental disabilities through surveillance, epidemiologic research, 
and applies research of preventive interventions; (8) coordinates activities with other CDC 
functional units, HHS, other federal agencies and appropriate private organizations regarding 
research and prevention programs for developmental disabilities; (9) collaborates with 
international organizations in developing strategies for the prevention of developmental 
disabilities; (10) disseminates findings of research through direct contact with health authorities, 
publication and distribution of special reports, publication in scientific and technical journals, 
conference presentations, and other appropriate means; and (11) provides training in the 
epidemiology of developmental disabilities to professionals throughout the United States and 
abroad.  (Approved 3/22/2006) 
 
Division of Human Development and Disability (CUBC) 
 
(1) Conducts, analyzes, and disseminates disability surveillance data to identify: the distribution 
of disabilities in state populations; health conditions that occur with greater frequency among 
people with disabilities relative to those without disability; and risk and protective behaviors 
compared to people without disabilities; (2) assists States and localities with the development, 
monitoring and evaluation of blood spot screening and early hearing detection and intervention 
(EHDI) tracking and surveillance systems; (3) plans, establishes, and maintains systems of 
surveillance, including registries, for monitoring, evaluating, and disseminating information on 
disability and related conditions and detrimental child outcomes; (4) oversees and manages 
grants, cooperative agreements, contracts, and other funding instruments related to Division 
programs; (5) assists States and localities in developing their capacity for serving individuals 
with disabilities and secondary conditions (e.g., developing prevention strategies, providing 
training and technical consultation); (6) collaborates with universities, Federal, national, and 
State organizations to identify and address knowledge and research gaps in disability, hearing 
and vision loss, child development, and blood spot screening; (7) collaborates with universities 
and other organizations to investigate environmental, social, and technological supports to 
promote social participation and human development; (8) conducts applied research on public 
health aspects of normal and abnormal child development (e.g., early childhood, behavior 
problems in children); (9) conducts research on etiology of hearing loss and associated 
disabilities, cost and effectiveness of EHDI programs, family issues related to the EHDI 
programs and long-term benefits of early identification and intervention; (10) conducts research 
on interventions to prevent adverse child developmental outcomes; (11) conducts and 
disseminates research findings about people with disabilities, with special emphasis on women, 
children, and older persons; (12) develops and disseminates information on public health aspects 
of normal and abnormal child development (e.g., early childhood, hearing loss, behavior 
problems in children); (13) provides information and education to the public on disabilities; and 
(14) develops programs that seek to identify health risks, protective factors and measure the 
effectiveness of health promotion activities for prevention of conditions related to disability.  
(Approved 3/15/2002) 
 
Office of the Director (CUBC1) 
 
(1) Provides leadership and guidance on strategic planning and implementation, program priority 
setting, and policy development, to advance the mission of the division, NCBDDD, and CDC; 
(2) develops goals, objectives, and the budget; monitors progress and allocation of resources, and 
reports accomplishments, future directions, and resource requirements, (3) facilitates scientific, 
policy and program collaboration among divisions and centers, and between CDC and other 
federal/non-federal partners; (4) promotes advancement of science throughout the division, 
supports program evaluation, and ensures that research meets the highest standards in the field; 
(5) provides medical expertise and consultation to planning, projects, policies and program 
activities; (6) advises the NCBDDD Office of the Director on matters relating to human 
development and disability and coordinates division responses to requests for technical assistance 
or information on activities supported by the division; (7) develops and produces 
communications tools and public affairs strategies to meet the needs of division programs and 
mission; and (8) represents the division at official professional and scientific meetings, both 
within and outside of CDC.  (Approved 4/20/2011) 
 
Child Development and Disability Branch (CUBCB) 
 
(1) Collaborates with and provides technical assistance, consultation, and training to local, state, 
federal, and international agencies, universities, public and private organizations on optimal child 
development, disability, and health promotion of children with or at risk of disabilities;  
(2) promotes development of data standards and standardized procedures for data management 
and program effectiveness and costs for systems supporting optimal child development, and 
disability activities; (3) coordinates and collaborates on recommendations for policy development 
at the federal and state levels and with the private sector to promote social participation and 
optimal child development, including those with or at risk for disabilities; (4) provides scientific 
leadership and technical assistance in the development, application, improvement and evaluation 
of public health activities, systems, and interventions supporting optimal child development, 
including those with or at risk for disabilities; (5) conducts research to expand the knowledge 
base related to optimal early development and health of children with or at risk of disabilities, 
and investigates costs and effectiveness of intervention programs and systems; (6) supports the 
development and utilization of activities necessary for health promotion and prevention of 
secondary conditions in children of all ages who have or are at risk for disabilities and their 
families; (7) supports and enhances public health capacity, including surveillance and data 
sharing, for promoting optimal health and development of infants and children with or at risk for 
disabilities and their families across the lifespan; (8) develops and disseminates information from 
surveillance and epidemiologic research, health promotion and disease prevention strategies, and 
policies related to public health aspects of typical and atypical child development; and (9) 
provides leadership in health promotion and child development for infants and children with or at 
risk for delays or disabilities and their families. (Approved 4/20/2011) 
 
Disability Health Branch (CUBCC) 
 
(1) Collaborates with and provides technical assistance, consultation, and training to local, state, 
federal, and international agencies, universities and governmental and non-governmental 
organizations on disability and health related issues; (2) collaborates with local, state, federal, 
and international agencies, and appropriate governmental and non-governmental organizations to 
develop,  review, and implement policies that advance the health of people with disabilities 
across the lifespan; (3) provides scientific leadership in the development, application, extension, 
and improvement of health surveillance and tracking systems related to disability and health;  
(4) conducts and supports both qualitative and quantitative research to expand the knowledge 
base related to disability and health across the lifespan; (5) supports the development and 
utilization of secondary condition prevention activities for people with specific or categorical 
disabilities; (6) supports and coordinates state public health capacity for promoting the health of 
people with disabilities; (7) disseminates information from surveillance and health services 
research, epidemiological research, health promotion and disease prevention strategies, and 
policies related to disability and health; (8) establishes collaborative partnerships with public and 
private organizations of national and international stature to promote the health of people with 
disabilities; (9) collaborates with funded non-governmental agencies to disseminate best 
practices, identify areas of need, facilitate development and distribution of educational materials, 
and provide informational resources to states and affected populations and their caregivers; and 
(10) provides leadership in health promotion and disease prevention across the lifespan for 
individuals with disabilities. (Approved 4/20/2011) 
 
Division of Blood Disorders (CUBD) 
 
(1) Designs and manages a surveillance system to evaluate the incidence, morbidity, and 
mortality of hemophilia, blood diseases and other hereditary disorders; (2) plans, develops, and 
coordinates special surveys and populations studies in selected geographic areas to monitor and 
assess the complications of chronic blood diseases and chronic hereditary disorders; (3) collects, 
analyzes, and prepares reports to document the prevalence and incidence of blood diseases and 
chronic hereditary disorders in the United States and provides this information to the scientific 
community through reports, publications, and public access data sets; (4) designs and implements 
studies using the surveillance data to identify risk factors for the complication of blood diseases 
and chronic hereditary disorders, and evaluate the effectiveness of the prevention activities; (5) 
conducts applied and operational research related to disease definition, etiology, diagnosis, 
complications, and prevention of blood diseases and chronic hereditary disorders;  
(6) conducts epidemiologic studies in persons and their families with blood diseases and chronic 
hereditary disorders; (7) plans, develops, and coordinates special surveys and populations studies 
in selected geographic areas to monitor and assess the complications of blood diseases and 
chronic hereditary disorders; (8) provides epidemiologic and medical consultation and technical 
assistance, including epidemic aids, to State and local health departments, other governmental 
agencies, and other public and private organizations in the investigation of blood diseases and 
chronic hereditary disorders; (9) designs and implements studies to evaluate the effectiveness of 
implemented prevention strategies in the prevention centers; (10) conducts applied research to 
develop, evaluate, improve, and standardize the methods and procedures used for the 
classification, surveillance, and prevention of blood diseases and chronic hereditary disorders; 
(11) participates in research on the prevention of the chronic complications of blood diseases and 
hereditary disorders; (12) provides diagnostic support for epidemiologic studies and epidemic 
aids on emerging blood diseases and chronic hereditary disorders; (13) determines the 
mechanisms of pathogenesis and complications of blood diseases and chronic hereditary 
disorders; (14) conducts research and provides reference services on diagnostic techniques for 
blood diseases and other hereditary disorders; (15) maintains the national reference laboratory for 
blood diseases and chronic hereditary disorders; (16) conducts research to improve laboratory 
methodologies and materials.  (Approved 11/15/2006) 
 
Office of the Director (CUBD1) 
 
(1) Provides leadership and guidance on strategic planning and implementation, program priority 
setting, and policy development, to advance the mission of the Division of Blood Disorders, 
NCBDDD and CDC; (2) develops goals, objectives, and budget; monitors progress and 
allocation of resources, and reports accomplishments, future directions, and resource 
requirements; (3) facilitates scientific, policy and program collaboration among divisions and 
centers, and between CDC and other federal/non-federal partners; (4) promotes advancement of 
science throughout the division, supports program evaluation, and ensures that research meets the 
highest standards in the field; (5) provides medical expertise and consultation to planning, 
projects, policies and program activities; (6) advises the Office of the Director of NCBDDD on 
matters relating to prevention of complications due to blood disorders and coordinates division 
responses to requests for technical assistance or information on activities supported by the 
division; (7) develops and produces communications tools and public affairs strategies to meet 
the needs of division programs and mission; (8) represents the division at official professional 
and scientific meetings, both within and outside of CDC; (9) applies evaluation and prevention 
effectiveness functions in the assessment of blood disorder programs, projects and activities,  
(10) develops, implements and evaluates long term plans for surveillance, research and 
prevention activities pertaining to blood disorders; and (11) drafts and disseminates reports of 
future plans and needs to inform policy. (Approved 06/21/2010) 
 
Epidemiology and Surveillance Branch (CUBDB)  
(1) Provides scientific leadership in the design and implementation of monitoring systems as well 
as designs and conducts epidemiologic and genetic research to identify causes, risk factors and 
complications of blood disorders in affected populations; (2) designs and manages surveillance 
systems to evaluate the incidence, morbidity, and mortality associated with blood diseases and 
disorders; (3) plans, develops and coordinates special surveys and populations studies to monitor 
and assess the complications of blood disorders; (4) designs and implements studies using 
surveillance data to identify risk factors for the complications of blood disorders, and evaluating 
the effectiveness of the prevention activities; (5) provides epidemiologic and medical 
consultation and technical assistance, including epidemic aids to state and local health 
departments, other governmental agencies, and other public and private institutions in the 
investigation of blood disorders and related complications; (6) designs and implements studies to 
evaluate the effectiveness of implemented prevention strategies in the treatment centers;  
(7) works closely with internal and external organizations in applying prevalence and incidence data 
to target and evaluate programs to prevent the complications of blood diseases and chronic hereditary 
disorders; (8) publishes findings and advances arising out of surveillance and epidemiologic 
research to the scientific and public health communities; (9) provides training services to states, 
localities, and other countries in investigation, diagnosis, prevention, and control of blood diseases 
and chronic hereditary disorders; (10) assists in designing, implementing, and evaluating prevention 
and counseling programs for persons and their families with chronic blood diseases and selected 
chronic hereditary disorders; (11) designs, implements and coordinates the prevention and 
surveillance activities of specialized federally funded prevention centers organized to prevent the 
complications of blood diseases and chronic hereditary disorders; (12) conducts and supports both 
qualitative and quantitative research to expand the knowledge base related to blood disorders 
across the lifespan; (13) collaborates with hemostasis laboratory branch and incorporates the 
findings of these branches’ activities which leads to prevention of complications of blood disorders; 
(14) supports public health analysis to include facilitating data collection, data management, data 
manipulation, analysis, project reporting and presentation; and (15) conducts applied research to 
develop, evaluate, improve and standardize public information systems and educational modules 
which support the prevention of complications from blood disorders.  (Approved 1/28/2016) 
 
Hemostasis Laboratory Branch (CUBDC) 
(1) Identifies new genetic markers of risk factors and clotting defects for affected groups; 
(2) provides reference laboratory diagnosis for multi-site epidemiologic and surveillance studies;  
(3) develops techniques and interpretation methods to improve molecular and coagulation diagnosis; 
(4) provides diagnostic support for epidemiologic studies and epidemic aids on emerging blood 
disorders and chronic hereditary disorders; (5) determines the mechanisms of pathogenesis and 
complications of blood disorders and chronic hereditary disorders; (6) conducts research and 
providing reference services on diagnostic techniques for blood disorders and chronic hereditary 
disorders; (7) conducts research to improve laboratory methodologies and materials; (8) where 
appropriate, maintains the national reference laboratory for blood disorders and chronic hereditary  
disorders; (9) works closely with entities and organizations within the agency and organizations 
external to the agency to provide laboratory services in support of projects whose primary aim is to 
prevent and reduce complications associated with blood disorders and chronic hereditary disorders; 
and (10) publishes findings and advances arising out of surveillance and epidemiologic research to 
the scientific and public health communities. (Approved 1/28/2016)  
 
